LEADING PHARMA, LLC has sponsored the creation of one or more 401k plans.
Measure | Date | Value |
---|
2022 : LEADING PHARMA 401(K) PLAN 2022 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $246,639 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $434,919 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $405,362 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $902,701 |
Value of total assets at end of year | 2022-12-31 | $3,755,977 |
Value of total assets at beginning of year | 2022-12-31 | $3,944,257 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $29,557 |
Total interest from all sources | 2022-12-31 | $420 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Administrative expenses professional fees incurred | 2022-12-31 | $4,850 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $592,123 |
Participant contributions at end of year | 2022-12-31 | $13,209 |
Participant contributions at beginning of year | 2022-12-31 | $10,942 |
Participant contributions at end of year | 2022-12-31 | $17,733 |
Participant contributions at beginning of year | 2022-12-31 | $0 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-188,280 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $3,755,977 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $3,944,257 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $3,215,008 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $3,536,040 |
Interest on participant loans | 2022-12-31 | $420 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $499,506 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $397,275 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-656,482 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $310,578 |
Employer contributions (assets) at end of year | 2022-12-31 | $10,521 |
Employer contributions (assets) at beginning of year | 2022-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $405,362 |
Contract administrator fees | 2022-12-31 | $24,707 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | WISS & COMPANY LLP |
Accountancy firm EIN | 2022-12-31 | 221732349 |
2021 : LEADING PHARMA 401(K) PLAN 2021 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $1,437,902 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $172,963 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $148,490 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $1,026,016 |
Value of total assets at end of year | 2021-12-31 | $3,944,257 |
Value of total assets at beginning of year | 2021-12-31 | $2,679,318 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $24,473 |
Total interest from all sources | 2021-12-31 | $50 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Administrative expenses professional fees incurred | 2021-12-31 | $420 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $148,490 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $570,839 |
Participant contributions at end of year | 2021-12-31 | $10,942 |
Participant contributions at beginning of year | 2021-12-31 | $0 |
Participant contributions at end of year | 2021-12-31 | $0 |
Participant contributions at beginning of year | 2021-12-31 | $15,404 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $146,598 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $1,264,939 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $3,944,257 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $2,679,318 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $3,536,040 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $2,357,208 |
Interest on participant loans | 2021-12-31 | $50 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $397,275 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $296,512 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $411,836 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $308,579 |
Employer contributions (assets) at end of year | 2021-12-31 | $0 |
Employer contributions (assets) at beginning of year | 2021-12-31 | $10,194 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $148,490 |
Contract administrator fees | 2021-12-31 | $24,053 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | WISS & COMPANY LLP |
Accountancy firm EIN | 2021-12-31 | 221732349 |
2020 : LEADING PHARMA 401(K) PLAN 2020 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $1,275,510 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $42,627 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $33,024 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $862,862 |
Value of total assets at end of year | 2020-12-31 | $2,679,318 |
Value of total assets at beginning of year | 2020-12-31 | $1,446,435 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $9,603 |
Total interest from all sources | 2020-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $0 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Administrative expenses professional fees incurred | 2020-12-31 | $75 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $560,597 |
Participant contributions at end of year | 2020-12-31 | $15,404 |
Participant contributions at beginning of year | 2020-12-31 | $0 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $4,115 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $1,232,883 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $2,679,318 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $1,446,435 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $2,357,208 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $1,317,939 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $296,512 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $128,496 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $412,648 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $298,150 |
Employer contributions (assets) at end of year | 2020-12-31 | $10,194 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $0 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $33,024 |
Contract administrator fees | 2020-12-31 | $9,528 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Unqualified |
Accountancy firm name | 2020-12-31 | WISS & COMPANY LLP |
Accountancy firm EIN | 2020-12-31 | 221732349 |
2019 : LEADING PHARMA 401(K) PLAN 2019 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $982,435 |
Total income from all sources (including contributions) | 2019-12-31 | $982,435 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $116,334 |
Total of all expenses incurred | 2019-12-31 | $116,334 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $101,559 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $101,559 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $787,539 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $787,539 |
Value of total assets at end of year | 2019-12-31 | $1,446,435 |
Value of total assets at end of year | 2019-12-31 | $1,446,435 |
Value of total assets at beginning of year | 2019-12-31 | $580,334 |
Value of total assets at beginning of year | 2019-12-31 | $580,334 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $14,775 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $14,775 |
Total interest from all sources | 2019-12-31 | $0 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $30,176 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $30,176 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $30,176 |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $30,176 |
Administrative expenses professional fees incurred | 2019-12-31 | $130 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
Value of fidelity bond cover | 2019-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $101,559 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $515,317 |
Contributions received from participants | 2019-12-31 | $515,317 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $8,592 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $8,592 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $866,101 |
Value of net income/loss | 2019-12-31 | $866,101 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $1,446,435 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $1,446,435 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $580,334 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $580,334 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Investment advisory and management fees | 2019-12-31 | $4,890 |
Investment advisory and management fees | 2019-12-31 | $4,890 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $1,317,939 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $1,317,939 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $528,073 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $528,073 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2019-12-31 | $128,496 |
Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2019-12-31 | $128,496 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2019-12-31 | $52,261 |
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2019-12-31 | $52,261 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $164,720 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $164,720 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $263,630 |
Contributions received in cash from employer | 2019-12-31 | $263,630 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $101,559 |
Contract administrator fees | 2019-12-31 | $9,755 |
Contract administrator fees | 2019-12-31 | $9,755 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | WISS & COMPANY LLP |
Accountancy firm name | 2019-12-31 | WISS & COMPANY LLP |
Accountancy firm EIN | 2019-12-31 | 221732349 |
Accountancy firm EIN | 2019-12-31 | 221732349 |